1. Two-Year Outcomes of Prostatic Artery Embolization for Symptomatic Benign Prostatic Hyperplasia: An International, Multicenter, Prospective Study.
- Author
-
Sapoval, Marc, Bhatia, Shivank, Déan, Carole, Rampoldi, Antonio, Carnevale, Francisco, Bent, Clare, Tapping, Charles, Bongiovanni, Simone, Taylor, Jeremy, Brower, Jayson, Rush, Michael, McWilliams, Justin, and Little, Mark
- Subjects
Acute urinary retention ,Benign prostatic hyperplasia ,Embosphere® Microspheres ,International Prostate Symptom Score (IPSS) ,Lower urinary tract symptoms ,Prostatic artery embolization ,Quality of life ,Sexual Health Inventory for Men (SHIM) ,Humans ,Male ,Prostatic Hyperplasia ,Embolization ,Therapeutic ,Prospective Studies ,Aged ,Treatment Outcome ,Prostate ,Quality of Life ,Lower Urinary Tract Symptoms ,Middle Aged ,Surveys and Questionnaires ,Aged ,80 and over ,Urinary Retention - Abstract
PURPOSE: To describe clinical outcomes among patients with benign prostatic hyperplasia (BPH) 24 months following prostatic artery embolization (PAE). MATERIALS AND METHODS: This was an international, multicenter, prospective trial of males with BPH with lower urinary tract symptoms (LUTS) or acute urinary retention (AUR) treated with PAE. The primary outcome was the 12 month change in the International Prostate Symptom Score (IPSS) for patients referred for bothersome LUTS, or urinary catheter independence for patients treated for AUR. Secondary outcome measures included changes in IPSS at 3 and 24 months, changes in quality of life (QoL), changes in the Sexual Health Inventory for Men (SHIM) questionnaire, technical success rate, and adverse events (AEs). Data were summarized using descriptive statistics. RESULTS: Four hundred seventy-eight consecutive patients underwent PAE (bothersome LUTS: N = 405; AUR: N = 73), mean age was 70 years. For patients treated for bothersome LUTS, mean total IPSS at baseline was 21.8 and decreased to 9.3, 10.6, and 11.2 at 3, 12, and 24 months following PAE, respectively (all p
- Published
- 2024